Feed aggregator

The 9 US States with the Best Job Markets Hiring Now

Biospace news - Thu, 07/27/2023 - 02:00
The 9 US States with the Best Job Markets Hiring Now 7/27/2023

AbbVie and Calibr expand strategic collaboration to advance several preclinical and early-stage clinical assets

World Pharma News - Wed, 07/26/2023 - 10:00
AbbVie (NYSE: ABBV) and Calibr today announced an expanded strategic collaboration to advance several innovative preclinical and early-stage clinical assets across AbbVie's core therapeutic growth areas including immunology, oncology, neuroscience and other areas of interest. This partnership is an expansion of the collaboration AbbVie and Scripps Research formed in 2019 to develop a broad range of potential new and novel therapeutics.

UK Probes Weight Loss, Diabetes Drugs for Suicidal Ideation and Self-Harm Risk

Biospace news - Wed, 07/26/2023 - 02:00
UK Probes Weight Loss, Diabetes Drugs for Suicidal Ideation and Self-Harm Risk 7/26/2023

GSK Expects Slower Uptake of RSV Vaccine Amid Record Sales for Shingles Shot

Biospace news - Wed, 07/26/2023 - 02:00
GSK Expects Slower Uptake of RSV Vaccine Amid Record Sales for Shingles Shot 7/26/2023

Merck, Moderna Launch Pivotal Cancer Vaccine Trial for High-Risk Melanoma

Biospace news - Wed, 07/26/2023 - 02:00
Merck, Moderna Launch Pivotal Cancer Vaccine Trial for High-Risk Melanoma 7/26/2023

FibroGen CEO Resigns Amid Clinical Losing Streak, Layoffs

Biospace news - Wed, 07/26/2023 - 02:00
FibroGen CEO Resigns Amid Clinical Losing Streak, Layoffs 7/26/2023

FTC Lawsuit Holds Up IQVIA’s Advertising Acquisition of Propel Media

Biospace news - Wed, 07/26/2023 - 02:00
FTC Lawsuit Holds Up IQVIA’s Advertising Acquisition of Propel Media 7/26/2023

From Crisis to Cure: Unraveling the Cancer Drug Shortage and the FDA’s Role

Biospace news - Wed, 07/26/2023 - 02:00
From Crisis to Cure: Unraveling the Cancer Drug Shortage and the FDA’s Role 7/26/2023

Plasma and Cell and Gene Therapy Milestones Highlight R&D Growth at CSL

Biospace news - Wed, 07/26/2023 - 02:00
Plasma and Cell and Gene Therapy Milestones Highlight R&D Growth at CSL 7/26/2023

Study finds new, unexpected mechanism of cancer cell spread

World Pharma News - Tue, 07/25/2023 - 10:00
A surprising finding from USC reveals key details about how cancer cells metastasize and suggests new therapeutic approaches for halting their spread.

The research, supported by the National Institutes of Health, centers on a cellular chaperone protein known as GRP78, which helps regulate the folding of other proteins inside cells.

Biogen to Cut 1,000 Jobs as Part of $1B Cost Savings Plan

Biospace news - Tue, 07/25/2023 - 02:00
Biogen to Cut 1,000 Jobs as Part of $1B Cost Savings Plan 7/25/2023

Roche Decides Not to Exercise Solid Tumor Option with SQZ

Biospace news - Tue, 07/25/2023 - 02:00
Roche Decides Not to Exercise Solid Tumor Option with SQZ 7/25/2023

Elevar Touts First-line Potential of Rivoceranib in Phase III Liver Cancer Trial

Biospace news - Tue, 07/25/2023 - 02:00
Elevar Touts First-line Potential of Rivoceranib in Phase III Liver Cancer Trial 7/25/2023

ImmunoGen Inks Cancer ADC Partnership with ImmunoBiochem

Biospace news - Tue, 07/25/2023 - 02:00
ImmunoGen Inks Cancer ADC Partnership with ImmunoBiochem 7/25/2023

Alvotech Expands Biosimilar Collaboration with Teva Amid Manufacturing Woes

Biospace news - Tue, 07/25/2023 - 02:00
Alvotech Expands Biosimilar Collaboration with Teva Amid Manufacturing Woes 7/25/2023

Potent anti-cancer therapy created using 'click chemistry'

World Pharma News - Mon, 07/24/2023 - 10:00
A potent anti-cancer therapy has been created using Nobel prize-winning "click chemistry", where molecules click together like LEGO bricks, in a new study by UCL and Stanford University researchers.

The study, published in Nature Chemistry, opens up new possibilities for how cutting-edge cancer immunotherapies might be built in future.

Pfizer announces New England Journal of Medicine publication on Group B Streptococcus (GBS) maternal vaccine candidate

World Pharma News - Fri, 07/21/2023 - 10:00
Pfizer Inc. (NYSE: PFE) announced data from a Phase 2 study investigating its hexavalent capsular polysaccharide (CPS) conjugate Group B Streptococcus (GBS) vaccine candidate, GBS6, being developed for maternal administration to protect infants against invasive GBS disease. In stage two of the three-part study, which enrolled 360 healthy pregnant individuals, GBS6 generated robust maternal antibody responses against the six GBS CPS serotypes included in the vaccine, and these antibodies were efficiently transferred to infants at ratios of ~0.4-1.3 depending on GBS6 group.

Week in Review: FTC Gets Tougher on Mergers, AAIC Data Dump, and J&J’s Q2 Beat

Biospace news - Fri, 07/21/2023 - 02:00
Week in Review: FTC Gets Tougher on Mergers, AAIC Data Dump, and J&J’s Q2 Beat 7/21/2023

Daiichi Sankyo’s FLT3 Inhibitor Gets FDA Nod as First-Line AML Treatment

Biospace news - Fri, 07/21/2023 - 02:00
Daiichi Sankyo’s FLT3 Inhibitor Gets FDA Nod as First-Line AML Treatment 7/21/2023

ADC Discontinues Zynlonta Trial in DLBCL After Seven Deaths

Biospace news - Fri, 07/21/2023 - 02:00
ADC Discontinues Zynlonta Trial in DLBCL After Seven Deaths 7/21/2023